Literature DB >> 12665175

Corticosteroid injection for treatment of de Quervain's tenosynovitis: a pooled quantitative literature evaluation.

Carlton A Richie1, William W Briner.   

Abstract

BACKGROUND: There have been many approaches described to treat de Quervain's tenosynovitis, but no definite consensus emerges in the literature. We conducted a pooled quantitative literature evaluation to review the therapeutic studies in the English language to determine the various reported cure rates.
METHODS: All citations in the MEDLINE and Ovid databases that addressed de Quervain's tenosynovitis were independently reviewed. Appropriate studies from the bibliographies of these articles were then obtained. Of the 35 articles on de Quervain's temosynovitis that were found in the modern literature, only seven allowed for comparison among potentially effective treatments. Studies were included if they evaluated or compared treatment options among patients and had defined criteria for diagnosis and successful treatment. These seven studies were descriptive, not comparative. In other words, each study reported the proportion of successful outcomes with different treatments, without a comparison to a specified control group. Four hundred fifty-nine wrists were subjected to one of several therapeutic modalities.
RESULTS: There was an 83% cure rate with injection alone. This rate was much higher than any other therapeutic modality (61% for injection and splint, 14% for splint alone, 0% for rest or nonsteroidal anti-inflammatory drugs).
CONCLUSION: It seems that injection alone is the best therapeutic approach to de Quervain's tenosynovitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665175     DOI: 10.3122/jabfm.16.2.102

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  31 in total

1.  Conservative care of De Quervain's tenosynovitis/ tendinopathy in a warehouse worker and recreational cyclist: a case report.

Authors:  Emily R Howell
Journal:  J Can Chiropr Assoc       Date:  2012-06

2.  Conservative management of De Quervain's stenosing tenosynovitis: a case report.

Authors:  John A Papa
Journal:  J Can Chiropr Assoc       Date:  2012-06

Review 3.  Radiological intervention of the hand and wrist.

Authors:  Annu Chopra; Emma L Rowbotham; Andrew J Grainger
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

4.  De Quervain's disease: efficacy of intra-sheath triamcinolone injection.

Authors:  Takuya Sawaizumi; Mitsuhiko Nanno; Hiromoto Ito
Journal:  Int Orthop       Date:  2006-06-08       Impact factor: 3.075

5.  Variations in the extensor grooves on the radial styloid process in Chinese population.

Authors:  Liang Xiao; Yi-kai Li; Gan-hu Ye; Xian-wen Yang
Journal:  Surg Radiol Anat       Date:  2012-06-29       Impact factor: 1.246

6.  The anatomy of the fibrous and osseous components of the first extensor compartment of the wrist: a cadaveric study.

Authors:  Ilke A Gurses; Osman Coskun; Ozcan Gayretli; Aysin Kale; Adnan Ozturk
Journal:  Surg Radiol Anat       Date:  2015-02-03       Impact factor: 1.246

7.  Nonsurgical Treatment of De Quervain Tenosynovitis: A Prospective Randomized Trial.

Authors:  Joseph A Ippolito; Spencer Hauser; Jay Patel; Michael Vosbikian; Irfan Ahmed
Journal:  Hand (N Y)       Date:  2018-07-30

8.  Sex differences in the radial grooves in the first extensor compartment.

Authors:  Ilke A Gurses; Rustu Turkay; Ercan Inci; Suna Ors; Yilmaz Onal; Sevda Ozel; Meltem Vural
Journal:  Skeletal Radiol       Date:  2016-04-04       Impact factor: 2.199

9.  Triggering of the abductor pollicis longus in association with deQuervain's tenosynovitis.

Authors:  Dustin Adam Greenhill; Joseph J Thoder; Hesham Abdelfattah
Journal:  BMJ Case Rep       Date:  2017-07-31

10.  Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice.

Authors:  Cyriac Peters-Veluthamaningal; Jan C Winters; Klaas H Groenier; Betty Meyboom-DeJong
Journal:  BMC Musculoskelet Disord       Date:  2009-10-27       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.